ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 947 filers reported holding ASTRAZENECA PLC in Q3 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,590,574 | -43.2% | 894,722 | -40.0% | 0.35% | -36.1% |
| Q2 2023 | $106,712,301 | +38.1% | 1,491,020 | +33.9% | 0.54% | +32.0% |
| Q1 2023 | $77,284,912 | +0.5% | 1,113,455 | -1.9% | 0.41% | -1.0% |
| Q4 2022 | $76,922,558 | +13.4% | 1,134,551 | -8.3% | 0.42% | +21.2% |
| Q3 2022 | $67,815,000 | -58.1% | 1,236,592 | -49.6% | 0.34% | -54.5% |
| Q2 2022 | $161,959,000 | +62.9% | 2,451,329 | +63.6% | 0.76% | +137.7% |
| Q1 2022 | $99,393,000 | +7176.2% | 1,498,242 | +6289.1% | 0.32% | +10500.0% |
| Q4 2021 | $1,366,000 | 0.0% | 23,450 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $1,366,000 | +0.3% | 22,744 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,362,000 | +20.4% | 22,744 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,131,000 | -67.2% | 22,744 | -67.0% | 0.00% | -66.7% |
| Q4 2020 | $3,446,000 | -55.4% | 68,938 | -51.2% | 0.01% | -59.1% |
| Q3 2020 | $7,735,000 | -11.4% | 141,149 | -14.5% | 0.02% | -24.1% |
| Q2 2020 | $8,730,000 | -32.5% | 165,069 | -43.0% | 0.03% | +3.6% |
| Q1 2020 | $12,938,000 | +72.4% | 289,690 | +92.4% | 0.03% | 0.0% |
| Q4 2019 | $7,506,000 | +15.7% | 150,534 | +3.4% | 0.03% | +12.0% |
| Q3 2019 | $6,486,000 | +51.8% | 145,534 | +40.6% | 0.02% | +56.2% |
| Q2 2019 | $4,274,000 | -12.8% | 103,528 | -14.6% | 0.02% | -20.0% |
| Q1 2019 | $4,904,000 | +23.8% | 121,284 | +16.3% | 0.02% | +11.1% |
| Q4 2018 | $3,961,000 | +20.0% | 104,284 | +25.0% | 0.02% | +50.0% |
| Q3 2018 | $3,300,000 | +63.7% | 83,408 | +45.3% | 0.01% | +50.0% |
| Q2 2018 | $2,016,000 | +1.4% | 57,408 | +1.0% | 0.01% | -11.1% |
| Q1 2018 | $1,988,000 | +112.2% | 56,860 | +110.6% | 0.01% | +125.0% |
| Q4 2017 | $937,000 | +15.3% | 27,000 | +12.5% | 0.00% | 0.0% |
| Q3 2017 | $813,000 | -61.5% | 24,000 | -61.3% | 0.00% | -60.0% |
| Q2 2017 | $2,114,000 | +13.2% | 62,000 | +3.3% | 0.01% | +11.1% |
| Q1 2017 | $1,868,000 | +55.4% | 60,000 | +36.4% | 0.01% | +28.6% |
| Q4 2016 | $1,202,000 | +103.4% | 44,000 | +144.4% | 0.01% | +133.3% |
| Q3 2016 | $591,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |